Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analysis of Helicobacter pylori-related prognostic gene modification patterns in the tumour microenvironment of gastric cancer. | Front Surg | 2022 | 36248367 | PubTator, text mining | PubMed |
| The Importance of Toll-like Receptor 9 Expression on Monocytes and Dendritic Cells in the Context of Epstein-Barr Virus Infection in the Immunopathogenesis of Primary Glomerulonephritis. | Int J Mol Sci | 2022 | 36233099 | PubTator, text mining | PubMed |
| Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion. | Int J Mol Sci | 2022 | 36233088 | PubTator, text mining | PubMed |
| Analysis of Epstein-Barr Virus (EBV) and PD-L1 Expression in Nasopharyngeal Carcinoma Patients in a Non-Endemic Region. | Int J Mol Sci | 2022 | 36233023 | PubTator, text mining | PubMed |
| A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | Int J Mol Sci | 2022 | 36232890 | PubTator, text mining | PubMed |
| Proviral ALV-LTR Sequence Is Essential for Continued Proliferation of the ALV-Transformed B Cell Line. | Int J Mol Sci | 2022 | 36232572 | PubTator, text mining | PubMed |
| Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation. | Cells | 2022 | 36231006 | PubTator, text mining | PubMed |
| Absence of Epstein-Barr virus DNA in anti-citrullinated protein antibody-expressing B cells of patients with rheumatoid arthritis. | Arthritis Res Ther | 2022 | 36229887 | PubTator, text mining | PubMed |
| Hodgkin's variant of Richter transformation during ibrutinib therapy: A case report and review of the literature. | Clin Case Rep | 2022 | 36225619 | PubTator, text mining | PubMed |
| Subtype distribution of lymphomas in northwestern Iran: a retrospective analysis of 659 cases according to World Health Organization classification. | BMC Cancer | 2022 | 36224530 | PubTator, text mining | PubMed |
| Proximity proteomics of synaptopodin provides insight into the molecular composition of the spine apparatus of dendritic spines. | Proc Natl Acad Sci U S A | 2022 | 36215465 | PubTator, text mining | PubMed |
| B cell-T cell interplay in immune regulation: A focus on follicular regulatory T and regulatory B cell functions. | Front Cell Dev Biol | 2022 | 36211467 | PubTator, text mining | PubMed |
| Primary small intestinal extranodal NK/T cell lymphoma, nasal type with kidney involvement: a rare case report and literature review. | Diagn Pathol | 2022 | 36199094 | PubTator, text mining | PubMed |
| Deciphering Spatial Protein-Protein Interactions in Brain Using Proximity Labeling. | Mol Cell Proteomics | 2022 | 36198386 | PubTator, text mining | PubMed |
| Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data. | BMC Med | 2022 | 36195867 | PubTator, text mining | PubMed |
| Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain. | Front Endocrinol (Lausanne) | 2022 | 36187123 | PubTator, text mining | PubMed |
| Integrated analysis of bulk and single-cell RNA sequencing reveals the interaction of PKP1 and tumor-infiltrating B cells and their therapeutic potential for nasopharyngeal carcinoma. | Front Genet | 2022 | 36186467 | PubTator, text mining | PubMed |
| M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma. | Front Immunol | 2022 | 36177006 | PubTator, text mining | PubMed |
| Updates of cancer hallmarks in patients with inborn errors of immunity. | Curr Opin Allergy Clin Immunol | 2022 | 36165433 | PubTator, text mining | PubMed |
| Evaluation of Epstein-Barr virus expression in oral squamous cell carcinomas. | Dent Res J (Isfahan) | 2022 | 36159061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=26